Receptor tyrosine kinase targeting in glioblastoma: performance, limitations and future approaches

From all central nervous system tumors, gliomas are the most common. Nowadays, researchers are looking for more efficient treatments for these tumors, as well as ways for early diagnosis. Receptor tyrosine kinases (RTKs) are major targets for oncology and the development of small-molecule RTK inhibi...

Descripción completa

Detalles Bibliográficos
Autores principales: Alexandru, Oana, Horescu, Cristina, Sevastre, Ani-Simona, Cioc, Catalina Elena, Baloi, Carina, Oprita, Alexandru, Dricu, Anica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2020
Materias:
Review Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7265959/
https://www.ncbi.nlm.nih.gov/pubmed/32514239
http://dx.doi.org/10.5114/wo.2020.94726

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7265959/
https://www.ncbi.nlm.nih.gov/pubmed/32514239
http://dx.doi.org/10.5114/wo.2020.94726

Ejemplares similares